Related Experiment Videos
Felty's syndrome: a case presentation
P L Grojec1, J H Soliman, C F Fuhrmann
1Harbor Hospital Center.
Maryland Medical Journal (Baltimore, Md. : 1985)
|November 1, 1993
Summary
A patient with Felty's syndrome died during hospitalization despite treatment with antibiotics, hydroxychloroquine sulfate, and gold salts. Autopsy revealed severe rheumatoid arthritis and complications including bronchopneumonia and splenomegaly.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Felty's syndrome is a rare autoimmune condition characterized by rheumatoid arthritis, splenomegaly, and neutropenia.
- Treatment often involves disease-modifying antirheumatic drugs (DMARDs) such as hydroxychloroquine sulfate and gold salts, alongside antibiotics for infections.
Observation:
- A 64-year-old male patient diagnosed with Felty's syndrome was admitted for treatment.
- The patient received a combination therapy including antibiotics, Plaquenil (hydroxychloroquine sulfate), and gold salts.
- Despite therapeutic interventions, the patient's condition deteriorated, leading to death in the fourth week of hospitalization.
Findings:
- Autopsy examination revealed extensive bronchopneumonia and fibrous pleuritis, indicating severe pulmonary complications.
- Significant findings included congestive splenomegaly, a hallmark of Felty's syndrome, and a congested passive liver.
- Histopathological analysis showed severe rheumatoid arthritis, reactive lymphoid hyperplasia, mild atherosclerosis, and hypercellular bone marrow.
Implications:
- This case highlights the potential severity and complex management of Felty's syndrome.
- The autopsy findings underscore the critical role of rheumatoid arthritis and associated complications in patient outcomes.
- Further research may explore optimal treatment strategies and prognostic factors for advanced Felty's syndrome.